Orthocell Achieves Strongest Month of U.S. Remplir™ Sales Since Launch

Contributed by: PR Newswire

Tags

Orthocell-Limited

More Like This

UPM Biomedicals launches FibGel™ the world's first injectable nanocellulose hydrogel for medical devices

PR Newswire associated0

MAYPHARM CO., LTD. Launches SKINCOLLA: The World's First Recombinant Human Collagen Filler for Superior Skin Rejuvenation

Bioretec Ltd´s business review Q1 2025: Strong net sales in the first quarter; CE approval with comprehensive indications received in January accelerates the future expansion of RemeOs products

Galderma Receives U.S. FDA Approval for Restylane® Contour™ for the Correction of Temple Hollowing

PR Newswire associated0

MARKING MAJOR MILESTONE OF 100,000 PATIENTS TREATED, NORDIC PHARMA, INC. (U.S.) ENHANCES ITS OFFERING AND INCREASES PROVIDER CONVENIENCE BY INCLUDING CANNULAS WITH ITS SHIPMENTS OF LACRIFILL® CANALICULAR GEL FOR TREATMENT OF DRY EYE SYMPTOMS

PR Newswire associated0

Contura Orthopedics Expands to Canada, Bringing Arthrosamid® to North America

Bioretec Ltd's half-year report January-June 2024: RemeOs™ trauma screw controlled launch in the U.S. yielded expected positive clinical results

Galderma’s Restylane® Volyme™ Demonstrates High Effectiveness, Satisfaction and a Robust Safety Profile in Chinese Patients With Temple Hollowing